Chemomab Therapeutics Ltd. (NASDAQ:CMMB)
| Market Cap | 16.31M+1.1% |
| Revenue (ttm) | 0 |
| Net Income | -7.60M+35.7% |
| EPS | -1.02+57.0% |
| Shares Out | 6.16M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 115,106 |
| Open | 2.60 |
| Previous Close | 2.47 |
| Day's Range | 2.57 - 2.74 |
| 52-Week Range | 1.35 - 3.58 |
| Beta | 0.66 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |
Chemomab Therapeutics Ltd. has a live Insider Score.
Scored on 0 qualifying trades from 0 insiders in the last 90 days.
About CMMB
Chemomab Therapeutics Ltd. operates as a clinical-stage biotechnology firm, dedicated to identifying and advancing novel treatments for inflammatory and fibrotic conditions. Its leading experimental drug candidate, CM-101, is a humanized monoclonal antibody specifically engineered to impede the core function of soluble chemokine CCL24. This potential therapy is currently under investigation for its efficacy in managing primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Established in 2011, the company, formerly known as Anchiano Therapeutics Ltd., adopted its current name, Chemomab Therapeutics Ltd., in March 2021 and is headquartered in Tel Aviv, Israel.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CMMB stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CMMB holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CMMB's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CMMB Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CMMB patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CMMB from public contracts
Source: USAspending.gov
CMMB Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CMMB’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score